New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment

Background. Dialysis treatment is improving, but several long-term problems remain unsolved, including metabolic bone disease linked to chronic kidney disease (CKD-MBD). The availability of new, efficacious but expensive drugs (intravenous calcimimetic agents) poses ethical problems, especially in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccoli, Giorgina Barbara, Trabace, Tiziana, Chatrenet, Antoine, Carranza de La Torre, Carlos Alberto, Gendrot, Lurlinys, Nielsen, Louise, Fois, Antioco, Santagati, Giulia, Saulnier, Patrick, Panocchia, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068561/
https://www.ncbi.nlm.nih.gov/pubmed/32075103
http://dx.doi.org/10.3390/ijerph17041238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068561/
https://www.ncbi.nlm.nih.gov/pubmed/32075103
http://dx.doi.org/10.3390/ijerph17041238

Ejemplares similares